SCHEMBL5650119

SCHEMBL5650119

CN(c1c2c(c(O)c3ncccc13)C(=O)N(Cc1c(F)cccc1F)C2)S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 8/20 0.39
SLC2A1 P11166 1/20 0.37
KDM4E B2RXH2 8/20 0.36
LMNA P02545 3/20 0.32
HTT P42858 3/20 0.32
HSP90AA1 P07900 3/20 0.32
RAB9A P51151 3/20 0.32
NPSR1 Q6W5P4 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
KMT2A Q03164 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TP53 P04637 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
ALOX15 P16050 2/20 0.32
CYP2C19 P33261 2/20 0.32
NPC1 O15118 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5649536 0.94 COMT (0.41) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL5647511 0.90 COMT (0.38) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL4652222 0.88 KDM4E (0.39) COMTKDM4ELMNAHTTHSP90AA1
SCHEMBL29390607 0.88 KDM4E (0.39) COMTKDM4ELMNAHTTHSP90AA1
SCHEMBL14607602 0.87 KDM4E (0.37) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL4692403 0.87 COMT (0.39) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL12378079 0.86 DHPS (0.39) COMTKDM4ELMNAHTTHSP90AA1
SCHEMBL4690938 0.86 COMT (0.41) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL4750464 0.86 COMT (0.41) COMTSLC2A1KDM4ELMNAHTT
SCHEMBL12415939 0.86 COMT (0.38) COMTKDM4ELMNAHTTHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072831-A1 Integrase inhibitor compounds TYMP, CDKN1A, PAICS COMT 645/4885SLC2A1 4646/4885KDM4E 1723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.